Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Abcellera Biologics Inc (NQ: ABCL ) 2.475 -0.095 (-3.70%) Streaming Delayed Price Updated: 3:13 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Abcellera Biologics Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs June 18, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ... Via Benzinga Exposures Product Safety Stocks That Hit 52-Week Lows On Thursday June 17, 2021 Before 10 a.m. ET on Thursday, 16 companies hit new 52-week lows. Areas of Interest: Vertex Pharmaceuticals (NASDAQ:VRTX) was the biggest company by market cap to... Via Benzinga The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme June 17, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,... Via Benzinga Exposures COVID-19 Dreary Day June 14, 2021 Another dreary day and a renewed boost for cryptocurrency - and away from the classic inflation hedge, gold. Via Talk Markets Happy Friday June 11, 2021 The inflation risk is being ignored by the US market now that there will probably not be a tax increase and may be higher prices for longer. Via Talk Markets AbCellera Announces Secondary Private Sale of 11.9 Million Common Shares June 10, 2021 From AbCellera Biologics Inc. Via Business Wire The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal June 10, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Aethlon Medical, Inc. (... Via Benzinga New New Deal Worries May 27, 2021 Nio is up 1.4% today on another round of Meme buying. Via Talk Markets The Surprising Move Vir Stock Made After Winning Covid Drug Authorization May 27, 2021 GlaxoSmithKline and Vir Biotechnology won Food and Drug Administration authorization for a Covid treatment on Wednesday, but Vir stock slipped Thursday. Via Investor's Business Daily Exposures COVID-19 60 Biggest Movers From Yesterday May 27, 2021 Gainers Lizhi Inc. (NASDAQ: LIZI) shares surged 57.6% to close at $6.84 on Wednesday. Flywire Corporation (NASDAQ: FLYW) gained 46.3% to settle at $35.10 after the company priced... Via Benzinga Sterling At Five-Year High May 25, 2021 Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro. Via Talk Markets Worldwide Upbeat May 21, 2021 The US crackdown on cryptocurrencies continues with the Fed today indicating that an official crypto-currency is going to be created for the USA. Via Talk Markets Topics Economy Exposures Interest Rates Another Tough Day For Markets May 17, 2021 The stock market resumed its negativism today mainly linked to fear of inflation and higher interest rates, on the argument that the most dangerous thing to believe is “it's different this time.” Via Talk Markets CORRECTING and REPLACING AbCellera Reports Q1 2021 Business Results May 14, 2021 From AbCellera Biologics Inc. Via Business Wire Friday Of The Heavy Week May 14, 2021 There is nothing like a pending weekend to push Wall Street into recuperation and this worked today Via Talk Markets Why AbCellera Stock Crumbled Despite In-Line Royalties For Covid Drug May 14, 2021 AbCellera stock crumbled Friday after the company guided to lower royalties from Covid treatment partner Eli Lilly in the second quarter. Via Investor's Business Daily AbCellera Biologics Inc. (ABCL) Q1 2021 Earnings Call Transcript May 13, 2021 ABCL earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial AbCellera Reports Q1 2021 Business Results May 13, 2021 From AbCellera Biologics Inc. Via Business Wire The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use May 13, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc... Via Benzinga Exposures COVID-19 AbCellera to Present Virtually at Berenberg Conference on May 18, 2021 May 11, 2021 From AbCellera Biologics Inc. Via Business Wire AbCellera Partners with Angios to Develop Therapeutics to Combat Blindness Caused by Diabetic Retinopathy May 06, 2021 From AbCellera Biologics Inc. Via Business Wire Finns and Danes May 05, 2021 Stock markets are still uncertain whether to rise or fall after the Tuesday debacle. Via Talk Markets Merry Month of May May 04, 2021 Today the unhinged markets of Monday went into normal mode as the rest of the world's markets re-opened. Via Talk Markets The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings May 09, 2021 Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... Via Benzinga Exposures COVID-19 Product Safety AbCellera-Lilly Partnered Second COVID-19 Antibody Enters Human Trials May 04, 2021 AbCellera Biologics Inc (NASDAQ: ABCL) has announced that a second antibody from its collaboration with Eli Lilly and Co (NYSE: LLY), LY-CoV1404, ... Via Benzinga Exposures COVID-19 New AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical Trials May 04, 2021 From AbCellera Biologics Inc. Via Business Wire 22 Stocks Moving in Monday's Pre-Market Session May 03, 2021 Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) rose 58.3% to $78.90 in pre-market trading. Nicholas Jason Singer disclosed a 9.13% passive stake in Brooklyn... Via Benzinga AbCellera Breaks Ground on Global Headquarters in Vancouver and Expects to Hire Hundreds of Scientific and Tech Professionals April 29, 2021 From AbCellera Via Business Wire Tuesday Market Report April 27, 2021 Swiss ABB gained 0.8% more today after it reported on its Q1 today, confirming the pre-announced data from earlier in April. Via Talk Markets London Cancel April 26, 2021 Brazilian Cosan is up 0.43% despite desperate Covid-19 outbreaks along the Amazon. Via Talk Markets Exposures COVID-19 < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.